These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 20379365)

  • 21. Recombinant virus vaccine-induced SIV-specific CD8+ cytotoxic T lymphocytes.
    Shen L; Chen ZW; Miller MD; Stallard V; Mazzara GP; Panicali DL; Letvin NL
    Science; 1991 Apr; 252(5004):440-3. PubMed ID: 1708168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effective Respiratory CD8 T-Cell Immunity to Influenza Virus Induced by Intranasal Carbomer-Lecithin-Adjuvanted Non-replicating Vaccines.
    Gasper DJ; Neldner B; Plisch EH; Rustom H; Carrow E; Imai H; Kawaoka Y; Suresh M
    PLoS Pathog; 2016 Dec; 12(12):e1006064. PubMed ID: 27997610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of human CD4+ and CD8+ T lymphocyte responses in experimental viral vaccine studies.
    Rothman AL; Yamada Y; Jameson J; Cruz J; West K; Green S; Ennis FA
    Dev Biol Stand; 1998; 95():95-104. PubMed ID: 9855419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen.
    Hanke T; Samuel RV; Blanchard TJ; Neumann VC; Allen TM; Boyson JE; Sharpe SA; Cook N; Smith GL; Watkins DI; Cranage MP; McMichael AJ
    J Virol; 1999 Sep; 73(9):7524-32. PubMed ID: 10438842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Helper-cytotoxic T lymphocyte (CTL) determinant linkage required for priming of anti-HIV CD8+ CTL in vivo with peptide vaccine constructs.
    Shirai M; Pendleton CD; Ahlers J; Takeshita T; Newman M; Berzofsky JA
    J Immunol; 1994 Jan; 152(2):549-56. PubMed ID: 8283036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV-1 proteins in infected cells determine the presentation of viral peptides by HLA class I and class II molecules and the nature of the cellular and humoral antiviral immune responses--a review.
    Becker Y
    Virus Genes; 1994 Jul; 8(3):249-70. PubMed ID: 7975271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Critical role for activation of antigen-presenting cells in priming of cytotoxic T cell responses after vaccination with virus-like particles.
    Storni T; Lechner F; Erdmann I; Bächi T; Jegerlehner A; Dumrese T; Kündig TM; Ruedl C; Bachmann MF
    J Immunol; 2002 Mar; 168(6):2880-6. PubMed ID: 11884458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunization with recombinant protein: conditions for cytotoxic T cell and/or antibody induction.
    Bachmann MF; Hengartner H; Zinkernagel RM
    Med Microbiol Immunol; 1994 Dec; 183(6):315-24. PubMed ID: 7596314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of cytotoxic T-cell responses by gene gun DNA vaccination with minigenes encoding influenza A virus HA and NP CTL-epitopes.
    Fomsgaard A; Nielsen HV; Kirkby N; Bryder K; Corbet S; Nielsen C; Hinkula J; Buus S
    Vaccine; 1999 Nov; 18(7-8):681-91. PubMed ID: 10547428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy.
    Diehl L; den Boer AT; Schoenberger SP; van der Voort EI; Schumacher TN; Melief CJ; Offringa R; Toes RE
    Nat Med; 1999 Jul; 5(7):774-9. PubMed ID: 10395322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of neonatal TH1 and CTL responses by live viral vaccines: a role for replication patterns within antigen presenting cells?
    Siegrist CA; Saddallah F; Tougne C; Martinez X; Kovarik J; Lambert PH
    Vaccine; 1998; 16(14-15):1473-8. PubMed ID: 9711791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of CTL response by a minimal epitope vaccine in HLA A*0201/DR1 transgenic mice: dependence on HLA class II restricted T(H) response.
    BenMohamed L; Krishnan R; Longmate J; Auge C; Low L; Primus J; Diamond DJ
    Hum Immunol; 2000 Aug; 61(8):764-79. PubMed ID: 10980387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses.
    Selin LK; Nahill SR; Welsh RM
    J Exp Med; 1994 Jun; 179(6):1933-43. PubMed ID: 8195718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endoplasmic reticulum targeting sequence enhances HBV-specific cytotoxic T lymphocytes induced by a CTL epitope-based DNA vaccine.
    Xu W; Chu Y; Zhang R; Xu H; Wang Y; Xiong S
    Virology; 2005 Apr; 334(2):255-63. PubMed ID: 15780875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biphasic CD8+ T-Cell Defense in Simian Immunodeficiency Virus Control by Acute-Phase Passive Neutralizing Antibody Immunization.
    Iseda S; Takahashi N; Poplimont H; Nomura T; Seki S; Nakane T; Nakamura M; Shi S; Ishii H; Furukawa S; Harada S; Naruse TK; Kimura A; Matano T; Yamamoto H
    J Virol; 2016 Jul; 90(14):6276-6290. PubMed ID: 27122584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incomplete CD8(+) T lymphocyte differentiation as a mechanism for subdominant cytotoxic T lymphocyte responses to a viral antigen.
    Spencer JV; Braciale TJ
    J Exp Med; 2000 May; 191(10):1687-98. PubMed ID: 10811862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasmid DNA vaccines are effective in the absence of IFNgamma.
    Hassett DE; Zhang J; Whitton JL
    Virology; 1999 Oct; 263(1):175-83. PubMed ID: 10544092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of cytotoxic T lymphocyte responses against hepatitis delta virus antigens which protect against tumor formation in mice.
    Mauch C; Grimm C; Meckel S; Wands JR; Blum HE; Roggendorf M; Geissler M
    Vaccine; 2001 Oct; 20(1-2):170-80. PubMed ID: 11567762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CTL-Promoting Effects of IL-21 Counteract Murine Lupus in the Parent→F1 Graft-versus-Host Disease Model.
    Nguyen V; Rus H; Chen C; Rus V
    J Immunol; 2016 Feb; 196(4):1529-40. PubMed ID: 26792801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Full length antigen priming enhances the CTL epitope-based DNA vaccine efficacy.
    Pouriayevali MH; Bamdad T; Parsania M; Sari RD
    Cell Immunol; 2011; 268(1):4-8. PubMed ID: 21324438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.